🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the companies withheld potential risks that the drug created to pediatric cognitive development.

This legal action arrives thirty days after Donald Trump publicized an unsubstantiated connection between using acetaminophen - referred to as paracetamol - throughout gestation and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which previously sold the medication, the exclusive pain medication suggested for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he said they "betrayed America by making money from suffering and marketing drugs ignoring the dangers."

The manufacturer states there is insufficient reliable data linking Tylenol to autism.

"These manufacturers deceived for years, knowingly endangering numerous people to boost earnings," Paxton, from the Republican party, said.

Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, the company also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a proven link between using paracetamol and autism."

Groups speaking for medical professionals and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in Tylenol - is a restricted selection for pregnant women to address pain and fever, which can present major wellness concerns if not addressed.

"In more than two decades of studies on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the usage of paracetamol in any trimester of pregnancy causes neurological conditions in offspring," the association stated.

This legal action cites latest statements from the previous government in arguing the drug is potentially dangerous.

In recent weeks, the former president caused concern from medical authorities when he advised expectant mothers to "resist strongly" not to take acetaminophen when unwell.

The US Food and Drug Administration then issued a notice that doctors should consider limiting the use of Tylenol, while also declaring that "a causal relationship" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to conduct "a massive testing and research effort" that would identify the cause of autism in a short period.

But authorities advised that identifying a unique factor of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and condition that impacts how individuals experience and engage with the world, and is identified using doctors' observations.

In his court filing, Paxton - a Trump ally who is running for federal office - alleges the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the science" around acetaminophen and autism spectrum disorder.

The case seeks to make the companies "eliminate any marketing or advertising" that asserts Tylenol is safe for women during pregnancy.

The Texas lawsuit parallels the complaints of a assembly of parents of young ones with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in recently.

A federal judge threw out the lawsuit, saying research from the parents' expert witnesses was lacking definitive proof.